349 related articles for article (PubMed ID: 37371831)
1. The Immunomodulatory Role of Cell-Free Approaches in SARS-CoV-2-Induced Cytokine Storm-A Powerful Therapeutic Tool for COVID-19 Patients.
Csobonyeiova M; Smolinska V; Harsanyi S; Ivantysyn M; Klein M
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371831
[TBL] [Abstract][Full Text] [Related]
2. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S
Inflamm Regen; 2020; 40():14. PubMed ID: 32582401
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cells and Their Extracellular Vesicles: A Potential Game Changer for the COVID-19 Crisis.
Kassem DH; Kamal MM
Front Cell Dev Biol; 2020; 8():587866. PubMed ID: 33102489
[TBL] [Abstract][Full Text] [Related]
5. Exosomes, and the potential for exosome-based interventions against COVID-19.
Rahmani A; Soleymani A; Almukhtar M; Behzad Moghadam K; Vaziri Z; Hosein Tabar Kashi A; Adabi Firoozjah R; Jafari Tadi M; Zolfaghari Dehkharghani M; Valadi H; Moghadamnia AA; Gasser RB; Rostami A
Rev Med Virol; 2024 Jul; 34(4):e2562. PubMed ID: 38924213
[TBL] [Abstract][Full Text] [Related]
6. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments.
Gurunathan S; Kang MH; Kim JH
Front Immunol; 2021; 12():716407. PubMed ID: 34394121
[TBL] [Abstract][Full Text] [Related]
7. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
Atluri S; Manchikanti L; Hirsch JA
Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects.
Abdelgawad M; Bakry NS; Farghali AA; Abdel-Latif A; Lotfy A
Stem Cell Res Ther; 2021 Aug; 12(1):469. PubMed ID: 34419143
[TBL] [Abstract][Full Text] [Related]
9. Expediting Molecular Translational Approach of Mesenchymal Stem Cells in COVID-19 Treatment.
Balaji Easwaran V; Satarker S; V Gujaran T; John J; Veedu AP; George KT; Purayil DK; Beegum F; Mathew A; Vibhavari R; Chaudhari SS; Pai KSR
Curr Stem Cell Res Ther; 2023; 18(5):653-675. PubMed ID: 36424799
[TBL] [Abstract][Full Text] [Related]
10. Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury.
Vaka R; Khan S; Ye B; Risha Y; Parent S; Courtman D; Stewart DJ; Davis DR
Stem Cell Res Ther; 2022 Jan; 13(1):20. PubMed ID: 35033181
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells and their derived exosomes to combat Covid-19.
Yousefi Dehbidi M; Goodarzi N; Azhdari MH; Doroudian M
Rev Med Virol; 2022 Mar; 32(2):e2281. PubMed ID: 34363275
[TBL] [Abstract][Full Text] [Related]
12. Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19.
Motallebnezhad M; Omraninava M; Esmaeili Gouvarchin Ghaleh H; Jonaidi-Jafari N; Hazrati A; Malekpour K; Bagheri Y; Izadi M; Ahmadi M
Pathol Res Pract; 2023 Jan; 241():154280. PubMed ID: 36580795
[TBL] [Abstract][Full Text] [Related]
13. Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy.
Russo E; Corrao S; Di Gaudio F; Alberti G; Caprnda M; Kubatka P; Kruzliak P; Miceli V; Conaldi PG; Borlongan CV; La Rocca G
Cells; 2023 Jun; 12(12):. PubMed ID: 37371134
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19.
Hou XY; Danzeng LM; Wu YL; Ma QH; Yu Z; Li MY; Li LS
World J Stem Cells; 2024 Apr; 16(4):353-374. PubMed ID: 38690515
[TBL] [Abstract][Full Text] [Related]
15. The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19.
Gu J; Zhao Q; Han Z; Han Z
Curr Stem Cell Res Ther; 2021; 16(3):277-285. PubMed ID: 32729428
[TBL] [Abstract][Full Text] [Related]
16. Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19.
Chouw A; Milanda T; Sartika CR; Kirana MN; Halim D; Faried A
Regen Eng Transl Med; 2022; 8(1):43-54. PubMed ID: 33723519
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective.
Gupta A; Kashte S; Gupta M; Rodriguez HC; Gautam SS; Kadam S
Hum Cell; 2020 Oct; 33(4):907-918. PubMed ID: 32780299
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory extracellular vesicles: an alternative to cell therapy for COVID-19.
Gupta A; Shivaji K; Kadam S; Gupta M; Rodriguez HC; Potty AG; El-Amin SF; Maffulli N
Expert Opin Biol Ther; 2021 Dec; 21(12):1551-1560. PubMed ID: 33886388
[No Abstract] [Full Text] [Related]
19. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System.
Ellison-Hughes GM; Colley L; O'Brien KA; Roberts KA; Agbaedeng TA; Ross MD
Front Cardiovasc Med; 2020; 7():602183. PubMed ID: 33363221
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives.
Yao W; Shi L; Zhang Y; Dong H; Zhang Y
Stem Cell Res Ther; 2022 Mar; 13(1):124. PubMed ID: 35321737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
